Benet 75 mg Tablets Special Drug Use Surveillance: Long-term Use (12-month Treatment Survey)

Trial Profile

Benet 75 mg Tablets Special Drug Use Surveillance: Long-term Use (12-month Treatment Survey)

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Osteoporosis
  • Focus Adverse reactions
  • Sponsors Takeda
  • Most Recent Events

    • 13 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 25 Aug 2015 Planned End Date changed from 1 Oct 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.
    • 25 Aug 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top